CIR S.p.A. - Compagnie Industriali Riunite(CIR.MI)
No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 1,822 | 1,962 | 2,236 | 1,792 | 1,821 | 1,801 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | 16 | 18 | -0 | 33 | 132 | 28 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
CIR S.p.A. - Compagnie Industriali Riunite, based in Milan, Italy, primarily operates through its subsidiaries in two key sectors: automotive components and healthcare services. Its geographical reach is extensive, covering Italy, other European nations, North and South America, and Asia. Within its automotive components division, the company develops, manufactures, and sells a diverse range of products. This includes suspension components such as coil springs, stabilizer bars, torsion bars, stabilinkers, leaf springs, and track adjusters, catering to producers of cars, light and heavy commercial vehicles, earth-moving machinery, and railway rolling stock. It also provides precision springs for various applications across the automotive, electric solutions, lighting, train, and construction industries. Furthermore, CIR supplies filters for oil, petrol, diesel fuel, engine air, and cabin air to original equipment manufacturers, original equipment replacement suppliers, and the independent aftermarket. Its offerings extend to comprehensive air and cooling systems, including intake manifold systems, air induction systems, coolant pump modules, thermostat housings and ducts, and thermal management solutions. In the healthcare sector, the company manages nursing homes and specialized units for functional and psychiatric rehabilitation. It delivers essential care for severe cerebral injuries, neurological pathologies, and both traumatic and chronic-degenerative musculoskeletal conditions. In Italy specifically, CIR oversees the Ospedale Fratelli Montecchi hospital in Suzzara and the Villa dei Pini care home in Civitanova Marche. These healthcare services are provided under recognized brands such as Anni Azzurri, Santo Stefano, Neomesia, and Charleston.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
CIR S.p.A. - Compagnie Industriali Riunite (CIR.MI)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
CIR S.p.A. - Compagnie Industriali Riunite, based in Milan, Italy, primarily operates through its subsidiaries in two key sectors: automotive components and healthcare services. Its geographical reach is extensive, covering Italy, other European nations, North and South America, and Asia. Within its automotive components division, the company develops, manufactures, and sells a diverse range of products. This includes suspension components such as coil springs, stabilizer bars, torsion bars, stabilinkers, leaf springs, and track adjusters, catering to producers of cars, light and heavy commercial vehicles, earth-moving machinery, and railway rolling stock. It also provides precision springs for various applications across the automotive, electric solutions, lighting, train, and construction industries. Furthermore, CIR supplies filters for oil, petrol, diesel fuel, engine air, and cabin air to original equipment manufacturers, original equipment replacement suppliers, and the independent aftermarket. Its offerings extend to comprehensive air and cooling systems, including intake manifold systems, air induction systems, coolant pump modules, thermostat housings and ducts, and thermal management solutions. In the healthcare sector, the company manages nursing homes and specialized units for functional and psychiatric rehabilitation. It delivers essential care for severe cerebral injuries, neurological pathologies, and both traumatic and chronic-degenerative musculoskeletal conditions. In Italy specifically, CIR oversees the Ospedale Fratelli Montecchi hospital in Suzzara and the Villa dei Pini care home in Civitanova Marche. These healthcare services are provided under recognized brands such as Anni Azzurri, Santo Stefano, Neomesia, and Charleston.
